Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | |
| Sales | 20 | 31 | 142 |
| Gross Profit | 20 | 31 | 142 |
| Operating Expenses | 2,403 | 1,494 | 765 |
| Operating Income | -2,383 | -1,463 | -623 |
| Other Income | 63 | 21 | -40 |
| Pre-tax Income | -2,320 | -1,442 | -663 |
| Net Income Continuous | -2,320 | -1,442 | -663 |
| Net Income | $-2,320 | $-1,442 | $-663 |
| EPS Basic Total Ops | -0.09 | -0.06 | -0.04 |
| EPS Basic Continuous Ops | -0.09 | -0.06 | -0.04 |
| EPS Diluted Total Ops | -0.09 | -0.06 | -0.04 |
| EPS Diluted Continuous Ops | -0.09 | -0.06 | -0.04 |
| EBITDA(a) | $-2,440 | $-1,476 | $-621 |